Immunotherapy-based combination strategies for treatment of EGFR-TKI-resistant non-small-cell lung cancer.
Future Oncol. 2022 May;18(14):1757-1775. doi: 10.2217/fon-2021-0862. Epub 2022 Mar 2.
Future Oncol. 2022.
PMID: 35232247
Free article.
Review.